Thermo Fisher Scientific Inc. (ETR:TN8)

Market Cap	194.90B
Revenue (ttm)	41.42B
Net Income (ttm)	6.12B
Shares Out	n/a
EPS (ttm)	15.97
PE Ratio	31.85
Forward PE	n/a
Dividend	1.44 (0.28%)
Ex-Dividend Date	Dec 13, 2024

Volume	228
Average Volume	278
Open	512.50
Previous Close	514.30
Day's Range	511.00 - 515.20
52-Week Range	469.65 - 590.90
Beta	n/a
RSI	40.25
Earnings Date	Jan 29, 2025

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 122,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: TN8

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD